Published

Psilocybin and ayahuasca in treatment-resistant depression: clinical evidence, methodological constraints and ethical challenges: a narrative review

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Frontiers in Psychiatry
Date: 2026-09-15
Source: Crossref
DOI: 10.3389/fpsyt.2026.1858319
PubMed: Unavailable

Authors

Civardi Serena Chiara Besana Filippo Durbano Federico Toscano Marco Otto Maria Raffone Fabiola Dell’Osso Bernardo Maria Olivola Miriam

Watch author

Derived topics and classifications

psilocybin Depression Personality Change Clinical Trial Review Article Treatment-Resistant Depression Safety Adverse Events Clinical Trial

Citation graph

40 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

10.1038/s41598-024-62381-9 10.1155/da/5553491 10.1001/jamapsychiatry.2015.2688 10.3109/01612840.2013.831260 10.1016/s0140-6736(15)00390-6 10.1007/s11920-007-0064-0 10.1016/j.euroneuro.2012.07.005 10.1177/0706743716659417 10.1016/s0197-2456(03)00112-0 10.1016/s0006-3223(02)01670-0 10.1002/wps.21120 10.1016/j.jad.2013.10.043

Indexed papers citing this DOI

Psilocybin and ayahuasca in treatment-resistant depression: clinical evidence, methodological constraints and ethical challenges: a narrative review2026-09-15

Related papers

The psychedelic renaissance: can psilocybin possibly combat depression?International Journal of Surgery Global Health · 2022-11-01 Safety and Efficacy of Psilocybin-assisted Psychotherapy for Demoralization Syndrome in Patients Diagnosed With Advanced Stage Cancer: a Pilot StudyClinicalTrials.gov · 2026-03-18 Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges.Expert opinion on drug safety · 2022-06-01 Psychedelic exposure in pregnancy: a scoping review to inform perinatal drug safety and clinical counseling.Therapeutic advances in drug safety · 2026-01-01 Multianalytical Investigation of Psilocybe cubensis Mushrooms: Physicochemical Characterization and Biological Evaluation of Psilocybin and Psilocin CompoundsACS Omega · 2025-09-30 Opinion Mining of Erowid's Experience Reports on LSD and Psilocybin-Containing Mushrooms.Drug safety · 2025-05-01 Is the psychedelic experience an essential aspect of the therapeutic effect of serotonergic psychedelics? Conceptual, discovery, development and implementation implications for psilocybin and related agents.Expert opinion on drug safety · 2023-01-01 [DNA and chemical analyses of commercial fly agaric-related products].Shokuhin eiseigaku zasshi. Journal of the Food Hygienic Society of Japan · 2005-04-01